Cite

HARVARD Citation

    Lima, M. et al. (n.d.). P-148Nimotuzumab bi-weekly/low dose combined to chemotherapy in advanced pancreatic cancer: A clinical study. Annals of oncology. p. . [Online]. 
  
Back to record